Katrin Jennifer Svensson

Dana-Farber Cancer Inst

$3,827,463

Attributed

$4,004,463

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $827.3K · FY2016–25

$1M$750K$500K$250K$0

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,004,463 · 4

By mechanism

R01$2,739,841 · 1

R00$730,622 · 1

R43$354,000 · 1

K99$180,000 · 1

Top collaborators

James W Larrick1 shared

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Bruce M Spiegelman$59,708,812
Jeffrey A Meyerhardt$15,207,814
Jonathan Z Long$8,774,056
Mu A$348,556
Jane Delima Thomas$70,578

Others in their field

Top investigators on “Novel Therapeutics”

David Heimbrook · Leidos Biomedical Research, Inc.$355,066,875
Judith S. Currier · University Of California Los Angeles$321,442,024
Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
Sharon A Nachman · Johns Hopkins University$212,395,175

Research focus

Novel TherapeuticsMetabolicDiabetes MellitusPathway InteractionsAdipocytesFatty Acid Glycerol EstersProteinsAdipose TissueSignal TransductionAnimalsBiologicalFeedingBiochemicalInsulin ResistanceHigh Fat DietGlucose Tolerance TestKnockout MiceCell Surface ReceptorsBlood Glucose RegulationEnergy MetabolismChronicDiabeticGeneticEngineering